Replies to post #243582 on NorthWest Biotherapeutics Inc (NWBO)

[jondoeuk]

GILD would not have purchased KITE for just one therapy (see post #243539 and from the same R&D Day

Arie B. Says this slide illustrates why we're all here, what $KITE stands for. pic.twitter.com/eTHxM9BPyb

— Brad Loncar (@bradloncar) October 18, 2016

)

''Now WHEN DCVax can be proven to work in blood cancer, it'll be the end of CAR-T.''

CAR-T and CAR-NK cells [1,2] can wipe out pounds of cancer in a number of weeks in some cases. If you look at the PET scan above in that Tweet and the ones below it is clear no vaccine would be able to do this.

Refs:
1 https://pbs.twimg.com/media/DrrmVqWXcAArM2W.jpg
2 https://pbs.twimg.com/media/DrrmVreXgAAiTY8.jpg

[doubleb73]

Its called desperation. Just like BMY buying Celgene. These large pharma get pressured by their sinking stock price to make acquisitions that are over priced that don’t create shareholder returns most of the time.

CAR-T have long expensive roads ahead paved with toxicity risk.

Eventually a dendritic cell vaccine will be what they are chasing to partner with in new trials.